Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02363205
Other study ID # 2014/427-31
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date February 2015
Est. completion date December 2017

Study information

Verified date December 2023
Source Linkoeping University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to determine whether tailored internet-administrated cognitive behaviour therapy (CBT) is a feasible approach in the treatment of depressive symptoms and comorbid anxiety symptoms.


Description:

As above


Recruitment information / eligibility

Status Completed
Enrollment 70
Est. completion date December 2017
Est. primary completion date December 2017
Accepts healthy volunteers No
Gender All
Age group 15 Years to 19 Years
Eligibility Inclusion Criteria: - Be between the ages of 15-19 years old - Have symptoms of depression, major depression Exclusion Criteria: - Suicidal ideation - Alcohol addiction - other major primary psychiatric disorder - Ongoing psychological treatment - recent (during last 4 weeks) change in psychiatric medication

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Tailored Internet-administrated CBT-Treatment
Guided internet-delivered CBT with chat sessions

Locations

Country Name City State
Sweden Linköping University Linköping Östergotland

Sponsors (1)

Lead Sponsor Collaborator
Linkoeping University

Country where clinical trial is conducted

Sweden, 

Outcome

Type Measure Description Time frame Safety issue
Primary Beck Depression Inventory Change from baseline to post treatment, six months and 12 months post treatment. Baseline, post treatment, 6 months- and 12 months post treatment
Secondary Beck Anxiety Inventory (BAI) Change from baseline to post treatment, six months and 12 months post treatment. Baseline, post treatment, 6 months- and 12 months post treatment
Secondary Social Interaction Anxiety Scale (SIAS) Change from baseline to post treatment, six months and 12 months post treatment. Baseline, post treatment, 6 months- and 12 months post treatment
Secondary The General Self-Efficacy Scale (GSE) Change from baseline to post treatment, six months and 12 months post treatment. Baseline, post treatment, 6 months- and 12 months post treatment
Secondary Subscale Life activites, WHO Disability Assessment Schedule 2.0 (WHODAS 2.0) Change from baseline to post treatment, six months and 12 months post treatment. Baseline, post treatment, 6 months- and 12 months post treatment
Secondary Knowledge of CBT strategies (developed by the research group) Change from baseline to post treatment, six months and 12 months post treatment. Baseline, post treatment, 6 months- and 12 months post treatment
Secondary Patient Health Questionnaire (PHQ) Change from baseline to post treatment Baseline, post treatment, 6 months- and 12 months post treatment
Secondary The Mood and Feelings Questionnaire (MFQ) Change from baseline to post treatment, six months and 12 months post treatment. Baseline, post treatment, 6 months- and 12 months post treatment
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05777044 - The Effect of Hatha Yoga on Mental Health N/A
Recruiting NCT04977232 - Adjunctive Game Intervention for Anhedonia in MDD Patients N/A
Recruiting NCT04680611 - Severe Asthma, MepolizumaB and Affect: SAMBA Study
Recruiting NCT04043052 - Mobile Technologies and Post-stroke Depression N/A
Completed NCT04512768 - Treating Comorbid Insomnia in Transdiagnostic Internet-Delivered Cognitive Behaviour Therapy N/A
Recruiting NCT03207828 - Testing Interventions for Patients With Fibromyalgia and Depression N/A
Completed NCT04617015 - Defining and Treating Depression-related Asthma Early Phase 1
Recruiting NCT06011681 - The Rapid Diagnosis of MCI and Depression in Patients Ages 60 and Over
Completed NCT04476446 - An Expanded Access Protocol for Esketamine Treatment in Participants With Treatment Resistant Depression (TRD) Who do Not Have Other Treatment Alternatives Phase 3
Recruiting NCT02783430 - Evaluation of the Initial Prescription of Ketamine and Milnacipran in Depression in Patients With a Progressive Disease Phase 2/Phase 3
Recruiting NCT05563805 - Exploring Virtual Reality Adventure Training Exergaming N/A
Completed NCT04598165 - Mobile WACh NEO: Mobile Solutions for Neonatal Health and Maternal Support N/A
Completed NCT03457714 - Guided Internet Delivered Cognitive-Behaviour Therapy for Persons With Spinal Cord Injury: A Feasibility Trial
Recruiting NCT05956912 - Implementing Group Metacognitive Therapy in Cardiac Rehabilitation Services (PATHWAY-Beacons)
Completed NCT05588622 - Meru Health Program for Cancer Patients With Depression and Anxiety N/A
Recruiting NCT05234476 - Behavioral Activation Plus Savoring for University Students N/A
Active, not recruiting NCT05006976 - A Naturalistic Trial of Nudging Clinicians in the Norwegian Sickness Absence Clinic. The NSAC Nudge Study N/A
Enrolling by invitation NCT03276585 - Night in Japan Home Sleep Monitoring Study
Terminated NCT03275571 - HIV, Computerized Depression Therapy & Cognition N/A
Completed NCT03167372 - Pilot Comparison of N-of-1 Trials of Light Therapy N/A